Diagnostic assessment to estimate and minimize neutron dose rates received by occupationally exposed individuals at cyclotron facilities.
Since 2003, radiopharmaceuticals for medical diagnostic purposes have been produced at the Instituto de Engenharia Nuclear, in Brazil, using two cyclotron accelerators - CV-28 and RDS111. As a result of the ever increasing production, a diagnostic assessment to reduce neutron dose rates received by occupationally exposed individuals during irradiation processes has been developed. The purpose of this work is to present this assessment, which is currently being applied to both the Fluorine and Iodine targets of CV-28 and RDS111 cyclotron accelerators.